CTMS Benchmarking And Market Dynamics

This report is the result of primary research conducted in Q3, 2021 and includes responses from 121 qualified CTMS decision-makers. These respondents are also members of the ISR Health Panel, a community of industry professionals that provides insight into drug development trends and outsourcing behavior.

If you yourself work for a CTMS provider, you can use this report to gain a better understanding of your company’s competitive position in the market and where you can offer advantages over other CTMS vendors. You’ll also learn which service attributes and technical capabilities sponsors value most when selecting a CTMS provider and how you can improve the next generation of CTMS to meet the needs of your end users.